RSV Vaccine Makers Hit Hard by New CDC Guidelines

RSV Vaccine Makers Hit Hard by New CDC Guidelines

Source: 
BioSpace
snippet: 

GSK, Moderna and Pfizer are all looking at potential respiratory syncytial virus vaccine sales slumps thanks to recently updated CDC guidelines regarding the use of RSV shots in seniors.